Dual Targeting of HDM2 and PPM1D As a Novel Therapeutic Approach for Myelofibrosis

被引：0
|
作者：
Marcellino, Bridget K. [1 ]
Clementelli, Cara [2 ]
Beaumont, Kristin [3 ]
Schaniel, Christoph [2 ]
Lu, Min [4 ]
Chen, Karie [2 ]
Russel, Adena [2 ]
Mohammad, Ayman [2 ]
Nathan, Daniel I. [2 ]
Aronin, Jake [2 ]
Shih, Alan H. [2 ]
Sebra, Robert [3 ]
Hoffman, Ronald [2 ,5 ]
机构：
[1] Icahn Sch Med Mt Sinai, Div Hematol & Med Oncol, New York, NY 10029 USA
[2] Icahn Sch Med Mt Sinai, Div Hematol & Med Oncol, Tisch Canc Inst, New York, NY 10029 USA
[3] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY USA
[4] Icahn Sch Med Mt Sinai, Div Hematol & Med Oncol, Tisch Canc Inst, Elmhurst, NY USA
[5] MPN Res Consortium, New York, NY USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-170232
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Mechanistic validation of a clinical lead stapled peptide that reactivates p53 by dual HDM2 and HDMX targeting
    F Wachter
    A M Morgan
    M Godes
    R Mourtada
    G H Bird
    L D Walensky
    Oncogene, 2017, 36 : 2184 - 2190
  • [22] Development of Antibody-like Proteins Targeting the Oncogenic Ser/Thr Protein Phosphatase PPM1D
    Ikeura, Megumi
    Tashiro, Hiroto
    Yamagata, Yuka
    Saito, Hikaru
    Kobayashi, Tamaki
    Mizunuma, Masataka
    Yamazaki, Kazuki
    Baba, Keisuke
    Furukawa, Kazuhiro
    Chuman, Yoshiro
    PROCESSES, 2022, 10 (08)
  • [23] PPM1D accelerates proliferation and metastasis of osteosarcoma by activating PKP2
    He, X-L
    Xiao, Q.
    Zhou, Z-P
    Hui, C-Y
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (01) : 78 - 85
  • [24] Targeting Mutant PPM1D Sensitizes Diffuse Intrinsic Pontine Glioma Cells to the PARP Inhibitor Olaparib
    Wang, Zhaohui
    Xu, Cheng
    Diplas, Bill H.
    Moure, Casey J.
    Chen, Chin-Pu Jason
    Chen, Lee H.
    Du, Changzheng
    Zhu, Huishan
    Greer, Paula K.
    Zhang, Liwei
    He, Yiping
    Waitkus, Matthew S.
    Yan, Hai
    MOLECULAR CANCER RESEARCH, 2020, 18 (07) : 968 - 980
  • [25] Rationally Designed Polypharmacology: α-Helix Mimetics as Dual Inhibitors of the Oncoproteins Mcl-1 and HDM2
    Conlon, Ivie L.
    Drennen, Brandon
    Lanning, Maryanna E.
    Hughes, Samuel
    Rothhaas, Rebecca
    Wilder, Paul T.
    MacKerell, Alexander D., Jr.
    Fletcher, Steven
    CHEMMEDCHEM, 2020, 15 (18) : 1691 - 1698
  • [26] Phospholipase D stabilizes HDM2 through an mTORC2/SGK1 pathway
    Lyo, Donggon
    Xu, Limei
    Foster, David A.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 396 (02) : 562 - 565
  • [27] Targeting PPM1D by lentivirus-mediated RNA interference inhibits the tumorigenicity of bladder cancer cells
    Wang, W.
    Zhu, H.
    Zhang, H.
    Zhang, L.
    Ding, Q.
    Jiang, H.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2014, 47 (12) : 1044 - 1049
  • [28] PPM1D modulates hematopoietic cell fitness and response to DNA damage and is a therapeutic target in myeloid malignancy
    Miller, Peter G.
    Sperling, Adam S.
    Mayerhofer, Christina
    McConkey, Marie E.
    Ellegast, Jana M.
    Da Silva, Carmen
    Cohen, Drew N.
    Wang, Chuqi
    Sharda, Azeem
    Yan, Ni
    Saha, Subha
    Schluter, Cameron
    Schechter, Ilexa
    Slabicki, Mikolaj
    Sandoval, Brittany
    Kahn, Josephine
    Boettcher, Steffen
    Gibson, Christopher J.
    Scadden, David T.
    Stegmaier, Kimberly
    Bhatt, Shruti
    Lindsley, R. Coleman
    Ebert, Benjamin L.
    BLOOD, 2023, 142 (24) : 2079 - 2091
  • [29] Novel chemical inhibitors specific for p53-inducible protein phosphatase PPM1D
    Yagi, Hiroaki
    Chuman, Yoshiro
    Yoshimura, Fumihiko
    Tanino, Keiji
    Sakaguchi, Kazuyasu
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
  • [30] Biallelic null mutations in PPM1D cause a novel combined immunodeficiency with severe neurodevelopmental defects
    Sole, Ana Esteve
    Gonzalez-Granado, Luis Ignacio
    Boast, Brigette
    Niemela, Julie E.
    Stoddart, Jennifer L.
    Silva, Agustin G.
    Pias, Leticia
    Bolasell, Merce
    Marin, Ana V.
    Regueiro, Jose R.
    Alsina, Laia
    Martine, Pierre
    Brown, Kate
    Apella, Ettore
    Francisco Quesada, Juan
    Sweeney, Colin L.
    Malech, Harry
    Haigh, Cathryn L.
    Kueh, HyeSun
    Rosenzweig, Sergio
    CLINICAL IMMUNOLOGY, 2024, 262
12345